|
Welcome to Articles4today.com
Blog!
Articles » Health & Fitness » Diabetes >> View Article
|
 |
|
 |
| Canadian Pharmacies Encourage Neural Stem Cell Transplant for Type 1 Diabetes Cure |
By:
Tanya Crane |
|
Japanese researchers have come up with viable treatment plans for type 1 diabetes. A new study encourages transplanting patients’ neural stem cells to the pancreas. Canadian pharmacies encourage cell transplantation processes, as they have long been considered optimum treatment for the disease. The study was published in the Journal EMBO Molecular Medicine and has generated some interest among experts.
The process used up until now involved using pancreatic tissue donated by healthy individuals and transferring it to people suffering from type 1 diabetes. The process is not viable as healthy tissue is in shortage. Also, recipients often do not accept pancreatic tissue from donors. With the number of cases increasing year by year, early detection appear to be a better option along with the new process.
Neural stem cells obtained from a patient is the ideal solution to overcome donor and cell rejection problems. Cells are obtained from the patient's own brain. The question of rejection does not arise, as they are transferred to the pancreas and converted into beta cells capable of producing insulin. The process was initiated by researchers from the AIS the Institute in Tsukuba, Japan.
Tests were conducted on laboratory mice bred in conditions leading to deficiency in beta cells. Neural stem cells were then taken from their olfactory bulb and hippocampus containing the tissue. Once the tissue containing healthy neural stem cells was transferred to the pancreas, it started demonstrating characteristics of beta cells and began generating excess quantity of insulin. Blood sugar levels began normalizing.
Type 1 diabetes begins at an early age, and Canadian pharmacies point out a cure is yet to be found for the disease. The immune system in the body deteriorates to a level that begins a counter-productive mechanism destroying beta cells. The body loses capability of producing cells that generate insulin. Sufferers are then dependent on external sources of insulin for life.
The present study has raised hopes in the medical fraternity about reversing the process of beta cell damage with the help of tissue found within the patient’s own body. Regenerative medicine will find great use for the process in other areas of research as well. Further studies may be required, but if stem cells can be isolated and cultivated within the body, it will prove to be a renewable source of cells capable of reversing type 1 diabetes as well as other diseases in the future.
Researchers from Stanford University have already identified a molecular pathway leading to common treatment for both type 1 as well as type 2 diabetes. Molecules known as platelet-derived growth factor or PDGF enable the growth of new beta cells producing insulin in the pancreas, as per the researchers. As the source of beta cells has been identified, it becomes easier to manufacture medications that compensate less quantity of PDGF in people suffering from diabetes.
People suffering from the disease often buy insulin injections from Canadian pharmacies to compensate for its loss within the body. It is a lifelong process, but the new study presents an opportunity to control blood sugar naturally, which then encourages people to lead a normal, healthy life. |
|
|
 |
 |
 |
 |
|
|
